Psychotropic medications in Pediatric practice.
Pedro Javier Rodríguez Hernández1, Gemma Ochando Perales2, César Soutullo Esperón3
1Hospital de Día Infantil y Juvenil «Diego Matías Guigou y Costa», Servicio de Psiquiatría, Hospital Universitario Ntra. Sra. de Candelaria, Universidad de La Laguna, Sociedad de Psiquiatría Infantil de la AEP, Tenerife, Spain.
Anales De Pediatria
|March 6, 2026
Summary
This review covers common psychotropic medications for pediatric mental health conditions. Understanding these drugs, including those for attention-deficit/hyperactivity disorder (ADHD), depression, anxiety, and behavioral disorders, is crucial.
Area of Science:
- Child and Adolescent Psychiatry
- Pediatric Psychopharmacology
Background:
- Increasing prevalence of mental health disorders in children and adolescents.
- Necessity for understanding available psychotropic treatments in pediatric populations.
Purpose of the Study:
- To review the most commonly prescribed psychotropic medications for pediatric patients.
- To outline indications for these medications in treating childhood and adolescent mental health conditions.
Main Methods:
- Literature review of psychotropic medications used in children and adolescents.
- Focus on frequently prescribed drug classes and their therapeutic uses.
Main Results:
- Stimulant and nonstimulant medications are frequently used for attention-deficit/hyperactivity disorder (ADHD).
- Selective serotonin reuptake inhibitors (SSRIs) are common for pediatric depression and anxiety.
- Antipsychotic medications are prescribed for behavioral disorders in this age group.
Conclusions:
- Key psychotropic medication classes for pediatric mental health include ADHD treatments, SSRIs, and antipsychotics.
- Awareness of these medications and their indications is vital for managing pediatric mental health disorders.
Related Concept Videos
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
405
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
405
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
583
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
583
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
343
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
343
01:28Drug Therapy
353
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
353
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
304
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
304
01:26Psychosis: Goals of Pharmacotherapy
646
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
646